Terrence Jao1 and Krishna Nayak2
1Biomedical Engineering, University of Southern California, Los Angeles, CA, United States, 2Electrical Engineering, University of Southern California, Los Angeles, CA, United States
Synopsis
Arterial
spin labeled CMR is a non-contrast myocardial perfusion imaging technique
capable of assessing coronary artery disease. A limitation of current methods
is potential underestimation of blood flow to myocardial segments that have
coronary arterial transit time longer than 1 R-R, which are found in regions
with significant collateral development from chronic myocardial ischemia. In
this work, we demonstrate the feasibility of a velocity selective labeling
scheme for ASL-CMR that is insensitive to arterial transit time. Introduction
Arterial spin labeling of the heart has been shown to estimate
myocardial perfusion and perfusion reserve for coronary artery disease
assessment.
1 However, current spatial labeling methods suffer from
transit delay effects when imaging is extended to more than a single slice.
Velocity selective (VS) labeling is a promising alternative that does not
suffer from transit delay effects.
2Methods
Images were acquired using a 3T GE Signa Excite HD scanner with an
8-channel cardiac coil in 12 healthy volunteers. Myocardial ASL measurements
were made at a single short axis slice using both VSASL and conventional flow
alternating inversion recovery (FAIR) ASL as a reference.
1,2 Figure
1 shows the VS pulse, which consists of a symmetric BIR4
for reduced eddy current sensitivity
3 and bipolar gradients to
prevent spatial signal modulation in static tissue.
4 The
VS labeling pulse was executed during mid-diastole when coronary blood flow is
high (>15-40 cm/s)
5 and myocardial velocity is low (< 2 cm/s)
6 to increase labeling efficiency and avoid spurious myocardial tagging. The
cutoff velocity was 10 cm/s and applied in the through-slice direction. An
additional triple inversion recovery background suppression preparation was
used to null myocardial T1s between 1250 ms and 1450 ms. Each scan consisted of
6 breath-held labeled/control image pairs. In a single volunteer, an additional
FAIR experiment was performed with a thick inversion slab to simulate whole
heart coverage with increased transit delay. Myocardial blood flow (MBF),
physiological noise (PN), and temporal SNR (TSNR = MBF/PN) were measured within
the left ventricular myocardium ROI.
Results and Discusssion
Figure 2 illustrates successful VS labeling of blood within the right
coronary artery in two subjects. VSASL performance in individual subjects are
summarized in Table 3. In 3 subjects, VSASL performance was poor (TSNR < 1) while
in the other 9, VSASL performed well with results comparable to the FAIR
reference scan. In the poor performers, MBF and PN measurements for VSASL and
FAIR were -0.13 ± 1.35 ml/g/min and 1.86 ± 0.42 ml/g/min respectively while in
good performers, they were 2.13 ± 0.48 ml/g/min and 1.97 ± 0.38 ml/g/min. We speculate
that the high PN in poor performers is from inconsistent pulse performance, possibly
due to variations in B1 and off-resonance, but have yet to test this. Poor
performance may also be from spurious labeling of myocardium, which can be
further reduced by more consistent background suppression. Low TSNR will be
addressed by further sequence improvements that explore different cutoff
velocities and velocity labeling directions.
In the volunteer in whom we performed FAIR with a thicker inversion slab
(FAIR-TS), MBF and PN measurements from VSASL, FAIR, and FAIR-TS were 1.38 ±
0.58 ml/g/min, 0.88 ± 0.37 ml/g/min, and -0.04 ± 0.24 ml/g/min respectively.
FAIR-TS suffered from a large transit delay and was unable to estimate MBF
while VSASL did not suffer from transit delay effects.
Conclusion
VS labeling has several important advantages over spatial labeling
sequences, notably its insensitivity to transit delay and its compatibility
with whole heart coverage. We have demonstrated the feasibility of VS labeling
of coronary blood and demonstrated that VSASL is sensitive to myocardial
perfusion. Performance of VSASL was comparable to FAIR in 75% of the subjects
scanned. In the other 25% of subjects, resolving the inconsistent performance is
still a work in progress.
Funding
American Heart Association 13GRNT13850012; Wallace H. Coulter Foundation
Clinical Translational Research Award.
Acknowledgements
No acknowledgement found.References
[1] Zun. et. al. MRM 2009; 62(4): 975-83
[2] Wong. et.
al. MRM 2006;55(6)1334-41
[3] Guo et.
al. MRM. 2015; 73(3):1085-94
[4] Fang et. al. MRM 2009; 62(6):1523-32
[5] Anderson et. al. Circ. 2000; 102(1):48-54
[6] Gorcsan III et. al. Am. Heart T. 1996; 131(6):1203-13